Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when PROK files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsProKidney holds routine annual meeting, elects three directors for 2029 terms
Filed May 29, 2026 · Period ending May 28, 2026 · ~1 min read
Key Changes
-
low
Stockholders elected William F. Doyle, Alan M. Lotvin, M.D., and Brian J.G. Pereira to three-year board terms expiring in 2029, each receiving over 193 million votes in favor with minimal opposition.
Item 5.07 verify on EDGAR → -
low
Ernst & Young LLP ratified as independent auditor for fiscal 2026 with 239 million votes in favor, representing continuity in the company's audit relationship.
Item 5.07 verify on EDGAR →
Summary
ProKidney held its 2026 Annual Meeting on May 28, conducting standard corporate governance business. Stockholders elected three directors to serve three-year terms through 2029 and ratified the company's existing auditor for the current fiscal year. All proposals passed with strong majority support and minimal opposition.
For retail investors, this filing represents routine annual compliance with no material changes to board composition or auditor relationships. The strong vote counts suggest shareholder alignment with management's recommendations. Watch for the company's proxy statement and annual report for more substantive updates on business strategy, financial performance, and executive compensation.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · May 30, 2026 · How we verify